Taken together, these data suggest super-enhancer-associated gene CAPG is a potential therapeutic target for AML, and the reliability of the integrate analysis approach based on super-enhancer, also a promising tool for predicting biomarkers of diseases. The gene discussed is CAPG; the disease is acute myeloid leukemia.